These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9618030)
1. Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture. Castro-Rivera E; Safe S J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):287-95. PubMed ID: 9618030 [TBL] [Abstract][Full Text] [Related]
2. 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context. Castro-Rivera E; Safe S J Steroid Biochem Mol Biol; 2003 Jan; 84(1):23-31. PubMed ID: 12648521 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
4. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. Hurd C; Dinda S; Khattree N; Moudgil VK Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683 [TBL] [Abstract][Full Text] [Related]
5. Effect of growth factors on estrogen receptor mediated gene expression. Hafner F; Holler E; von Angerer E J Steroid Biochem Mol Biol; 1996 Jul; 58(4):385-93. PubMed ID: 8903422 [TBL] [Abstract][Full Text] [Related]
6. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells. Castro-Rivera E; Wormke M; Safe S Mol Cell Endocrinol; 1999 Apr; 150(1-2):11-21. PubMed ID: 10411295 [TBL] [Abstract][Full Text] [Related]
7. Estrogen responses in bovine fetal uterine cells involve pathways directed by both estrogen response element and activator protein-1. Malayer JR; Cheng J; Woods VM Biol Reprod; 1999 May; 60(5):1204-10. PubMed ID: 10208985 [TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. Krishnan V; Wang X; Safe S J Biol Chem; 1994 Jun; 269(22):15912-7. PubMed ID: 8195246 [TBL] [Abstract][Full Text] [Related]
9. Effect of estrogens on IL-1beta promoter activity. Ruh MF; Bi Y; D'Alonzo R; Bellone CJ J Steroid Biochem Mol Biol; 1998 Aug; 66(4):203-10. PubMed ID: 9744517 [TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells. Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of creatine kinase specific activity in human osteoblast and endometrial cells by estrogens and anti-estrogens and its modulation by calciotropic hormones. Fournier B; Häring S; Kaye AM; Sömjen D J Endocrinol; 1996 Aug; 150(2):275-85. PubMed ID: 8869594 [TBL] [Abstract][Full Text] [Related]
12. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Duan R; Porter W; Safe S Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985 [TBL] [Abstract][Full Text] [Related]
13. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells. Weaver CA; Springer PA; Katzenellenbogen BS Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Wilson VS; Bobseine K; Gray LE Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400 [TBL] [Abstract][Full Text] [Related]
15. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Legler J; van den Brink CE; Brouwer A; Murk AJ; van der Saag PT; Vethaak AD; van der Burg B Toxicol Sci; 1999 Mar; 48(1):55-66. PubMed ID: 10330684 [TBL] [Abstract][Full Text] [Related]
16. SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. Hua W; Christianson T; Rougeot C; Rochefort H; Clinton GM J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):279-89. PubMed ID: 8541224 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Aronica SM; Katzenellenbogen BS Mol Endocrinol; 1993 Jun; 7(6):743-52. PubMed ID: 7689695 [TBL] [Abstract][Full Text] [Related]
19. Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay. Charles GD; Bartels MJ; Zacharewski TR; Gollapudi BB; Freshour NL; Carney EW Toxicol Sci; 2000 Jun; 55(2):320-6. PubMed ID: 10828263 [TBL] [Abstract][Full Text] [Related]
20. Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor. Levenson AS; Catherino WH; Jordan VC J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):261-8. PubMed ID: 9219916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]